You are here: Industry Insights > IPO

News List

Aptinyx seeks $80M IPO to push NMDA drug platform fiercebiotech
May 29, 2018
With the ink barely dry on a partnership deal with Allergan, Aptinyx has announced plans for an $80 million IPO to accelerate work on its drugs for neurological disorders.
Magenta eyes $100M IPO to help ‘lead a new era in transplant medicine’ fiercebiotech
May 29, 2018
Coming off the back of a healthy financing round just six weeks ago, stem cell biotech Magenta Therapeutics now wants more, and it wants to go public.
Provention Bio tees up for $50M IPO fiercebiotech
May 16, 2018
Provention Bio has filed to raise up to $50 million in its Nasdaq IPO, which will bankroll several clinical programs, including a pair of inflammatory bowel disease assets it picked up from Janssen last fall.
Biotech firm Ascletis first to apply for Hong Kong, S.A.R., China IPO biospectrumasia
May 14, 2018
The Hangzhou-based company is close to commercializing a new drug for hepatitis C in China.
U.S. Biotech Firm Stealth May Apply For Hong Kong, S.A.R., China IPO This Year biospectrumasia
May 14, 2018
Hong Kong, S.A.R., China’s exchange last month approved the biggest change to its IPO rules in two decades. It now accepts applications from unprofitable biotech businesses.
Early Thoughts On Autolus IPO newsnow
May 14, 2018
Autolus Therapeutics, a small British biotech company, has filed to go public.
Pharma-tech Company WuXi AppTec announces its IPO biospectrumasia
May 09, 2018
in Share .    The medical device company lists its initial public offering (IPO) of 104,198,600 shares of common stock, at a public offering price of RMB 21.60 per share
ASLAN prices IPO of its American depository shares biospectrumasia
May 08, 2018
Leerink Partners and Piper Jaffray & Co. are acting as joint book-running managers for this offering.
Inspire medical systems upsizes IPO biospectrumasia
May 07, 2018
Inspire Medical Systems has increased the size of its IPO to 6.75M shares (from 5M) priced at $14 - 16.
Kiniksa and Scholar Rock gun for $175M IPOs as 2 other biotechs fiercebiotech
May 02, 2018
It was something of an up-and-down week for IPOs: Two biotechs, Alzheimer’s focused Alzheon and brittle bone drug company Mereo BioPharma pulled their ...

Previous page 1 2 3 4 5 6 7 8 9 Next page